Related references
Note: Only part of the references are listed.Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer
Martin K. Bakht et al.
NATURE CANCER (2023)
An overview on the biological activity and anti-cancer mechanism of lovastatin
Liguo Xie et al.
CELLULAR SIGNALLING (2021)
Enzalutamide Enhances PSMA Expression of PSMA-Low Prostate Cancer
Magdalena Staniszewska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Concentration-dependent effects of dutasteride on prostate-specific membrane antigen (PSMA) expression and uptake of 177Lu-PSMA-617 in LNCaP cells
Benedikt Kranzbuhler et al.
PROSTATE (2019)
Role of Androgen Receptor in Prostate Cancer: A Review
Kazutoshi Fujita et al.
WORLD JOURNAL OF MENS HEALTH (2019)
Rapid Modulation of PSMA Expression by Androgen Deprivation: Serial 68Ga-PSMA-11 PET in Men with Hormone-Sensitive and Castrate-Resistant Prostate Cancer Commencing Androgen Blockade
Louise Emmett et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Clinical performance of 68Ga-PSMA-11 PET/MRI for the detection of recurrent prostate cancer following radical prostatectomy
Benedikt Kranzbuhler et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors
Charalambos Kaittanis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Pharmacological upregulation of prostate-specific membrane antigen (PSMA) expression in prostate cancer cells
Benedikt Kranzbuhler et al.
PROSTATE (2018)
Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer
Katharina Luckerath et al.
EJNMMI RESEARCH (2018)
68Ga-PSMA-11 PET Imaging of Response to Androgen Receptor Inhibition: First Human Experience
Thomas A. Hope et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Influence of Androgen Deprivation Therapy on the Uptake of PSMA-Targeted Agents: Emerging Opportunities and Challenges
Martin K. Bakht et al.
NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Simultaneous 68Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer
Matthias Eiber et al.
EUROPEAN UROLOGY (2016)
Sensitivity, Specificity, and Predictors of Positive 68Ga-Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis
Marlon Perera et al.
EUROPEAN UROLOGY (2016)
Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells in vitro and correlating with progression in vivo
Maria Elisa Perico et al.
ONCOTARGET (2016)
Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy
Matthias Eiber et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Multimodal image-guided prostate fusion biopsy based on automatic deformable registration
Oliver Zettinig et al.
INTERNATIONAL JOURNAL OF COMPUTER ASSISTED RADIOLOGY AND SURGERY (2015)
PSMA Expression is Highly Homogenous in Primary Prostate Cancer
Maria C. Tsourlakis et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2015)
Alterations in androgen deprivation enhanced prostate-specific membrane antigen (PSMA) expression in prostate cancer cells as a target for diagnostics and therapy
B. Meller et al.
EJNMMI RESEARCH (2015)
Androgen receptor: structure, role in prostate cancer and drug discovery
M. H. Eileen Tan et al.
ACTA PHARMACOLOGICA SINICA (2015)
Synergistic Co-Targeting of Prostate-Specific Membrane Antigen and Androgen Receptor in Prostate Cancer
Jose D. Murga et al.
PROSTATE (2015)
The direct inhibitory effect of dutasteride or finasteride on androgen receptor activity is cell line specific
Rishi Raj Chhipa et al.
PROSTATE (2013)
Noninvasive measurement of androgen receptor signaling with a positron-emitting radiopharmaceutical that targets prostate-specific membrane antigen
Michael J. Evans et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Statins Reduce the Androgen Sensitivity and Cell Proliferation by Decreasing the Androgen Receptor Protein in Prostate Cancer Cells
Akira Yokomizo et al.
PROSTATE (2011)
Lovastatin Causes Diminished PSA Secretion by Inhibiting AR Expression and Function in LNCaP Prostate Cancer Cells
Lin Yang et al.
UROLOGY (2011)
Chinese Red Yeast Rice Versus Lovastatin Effects on Prostate Cancer Cells With and Without Androgen Receptor Overexpression
Mee Young Hong et al.
JOURNAL OF MEDICINAL FOOD (2008)
Prostate-specific membrane antigen regulates angiogenesis by modulating integrin signal transduction
Rebecca E. Conway et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5α-reductase inhibitor
RV Clark et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer
A Ghosh et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Dutasteride, the dual 5α-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line
CB Lazier et al.
PROSTATE (2004)
Safety and tolerability of the dual 5α-reductase inhibitor dutasteride in the treatment of benign prostatic hyperplasia
GL Andriole et al.
EUROPEAN UROLOGY (2003)